The COVID-19 host genetics initiative brings together the human genetics community to generate, share, and analyze data to learn the genetic determinants of COVID-19 susceptibility, severity, and outcomes.
We can find effective treatments for COVID-19 much faster by sharing protocols for randomized clinical trials. This platform is a home for RCT protocols that are available for collaboration.
Due to the emergent need for better understanding of COVID-19 and the development of patient-specific clinical risk scores and early warning tools, CD2H has developed a platform to support analytic and machine learning hypotheses on clinical data.
“Scientists are a tremendous resource for this country, and it’s not something that should just be confined to the coasts,” Michael Wells said. “It’s something that everyone should be able to benefit from.”
The COVID-19 Consumer Data Protection Act would provide all Americans with more transparency, choice, and control over the collection and use of their personal health, geolocation, and proximity data.
Epic dropping opposition to a federal rule designed to improve patients’ access to their medical records, removing a potential barrier to its implementation.